Latent Tuberculosis Infection
Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study
8
Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia
7
Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study
10
Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV infected people in Spain
8
Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus infected persons
11
Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection
8
Risk of latent tuberculosis infection in children living in households with tuberculosis patients: a cross sectional survey in remote northern Lao People's Democratic Republic
9
Latent tuberculosis infection and associated risk factors among people living with HIV and apparently healthy blood donors at the University of Gondar referral hospital, Northwest Ethiopia
6
Global burden of latent multidrug-resistant tuberculosis : trends and estimates based on mathematical modelling
11
Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Nampula Central Hospital, Mozambique
10
Interaction of nutritional status and diabetes on active and latent tuberculosis: a cross sectional analysis
9
Estimation of the Prevalence of Latent Tuberculosis Infection among Household contacts of Sputum Culture Positive Tuberculosis Patients in Vellore, South India.
81
A scoping review of cost effectiveness of screening and treatment for latent tuberculosis infection in migrants from high incidence countries
11
The latent tuberculosis infection cascade of care in Iqaluit, Nunavut, 2012–2016
10
Initiation and completion rates for latent tuberculosis infection treatment: a systematic review
12
The use of anti-tuberculosis therapy for latent TB infection
10
QuantiFERON TB Gold In tube test for the diagnosis of active and latent tuberculosis in selected health facilities of Addis Ababa, Ethiopia
6
Point Counterpoint: Should Interferon Gamma Release Assays Become the Standard Method for Screening Patients for Mycobacterium tuberculosis Infections in the United States?
7
ORFeome based identification of biomarkers for serodiagnosis of Mycobacterium tuberculosis latent infection
8
Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine
8